Healthequity, Inc.
Congress has disclosed 15 buys and 9 sells of HQY (Healthequity, Inc.) in official financial disclosures, each linked to its original filing. A transparency record — not investment advice.
Activity Congressional Activity
Round-trip watch Still on the books
Members who disclosed buying HQY and have not disclosed selling, versus their own entry (the most recent disclosed buy). "Open" means no disclosed sale — never "still holds" — and the % is unrealised, on paper. Not investment advice.
| Member | Entry (last buy) | Entry price | Now | vs entry | Status |
|---|---|---|---|---|---|
| Gilbert Cisneros | 2026-07-10 | $94.40 | $102.47 | +8.5% | in profit |
Price as of 2026-10-30. Counted open while disclosed buys outnumber disclosed sells; tracks the price, not exact position size (amounts are ranges).
Fundamentals · FY2027 Valuation
Standard valuation multiples from SEC-reported GAAP financials (trailing twelve months), each compared to the median for Business Services. We use reported GAAP, not forward or adjusted earnings, so our figures can sit higher than sites that do — especially for companies with falling profit. Relative context — not a target price or investment advice.
how it's calculated
how it's calculated
how it's calculated
24 trades Recent Congressional Trades
Two things to watch per trade: the disclosure lag (how many days passed before the trade was made public) and the price move in that window (how the stock moved during those non-public days). A sell followed by a price drop, or a buy followed by a rise, means well-timed trading — visible here in the open. Note: the Score measures how notable a trade is, not whether it made money — the price move is shown for context and isn't part of it.
| Politician | Chamber | Type | Owner | Date | Disclosure lag | Price move in that window | Amount | Score | Source |
|---|---|---|---|---|---|---|---|---|---|
| Gilbert Cisneros | House | BUY ◆ insider convergence · moderate | Self · 150 Main Street Trust > Bank of America | 2026-07-10 | 35 days | +10.9% | $1K–$15K 0.1% of NW |
17.0 | ↗ filing |
| Gilbert Cisneros | House | BUY ◆ insider convergence · moderate | Self · 150 Main Street Trust > Bank of America | 2026-06-30 | 2 days | +5.5% | $1K–$15K 0.1% of NW |
14.1 | ↗ filing |
| Gilbert Cisneros | House | BUY ◆ insider convergence · moderate | Self · 150 Main Street Trust > Bank of America | 2026-05-29 | 7 days | +0.8% | $1K–$15K 0.1% of NW |
11.7 | ↗ filing |
| Lisa McClain | House | SELL ◆ insider convergence | Spouse · Charles Schwab Brokerage Account 924 | 2025-06-17 | 57 days | -10.7% | $1K–$15K 0.1% of NW |
33.3 | ↗ filing |
| Gilbert Cisneros | House | SELL ◆ insider convergence | Self · 150 Main Street Trust > Bank of America | 2025-06-16 | 22 days | +2.0% | $1K–$15K 0.1% of NW |
17.3 | ↗ filing |
| Lisa McClain | House | BUY ◆ insider divergence | Spouse · Charles Schwab Brokerage Account 924 | 2025-06-11 | 63 days | -14.6% | $1K–$15K 0.1% of NW |
63.6 | ↗ filing |
| Rob Bresnahan | House | SELL ◆ insider convergence · moderate | Joint · Joint Ownership LPL Account | 2025-01-13 | 0 days | 0.0% | $1K–$15K 0.2% of NW |
64.4 | ↗ filing |
| Josh Gottheimer | House | SELL ◆ insider convergence · moderate | Joint · Morgan Stanley - Select UMA Account # 1 | 2024-11-07 | 26 days | +4.3% | $1K–$15K <0.1% of NW |
0.7 | ↗ filing |
| Josh Gottheimer | House | SELL ◆ insider convergence | Joint · Morgan Stanley - Select UMA Account # 1 | 2024-06-21 | 17 days | — | $1K–$15K <0.1% of NW |
1.0 | ↗ filing |
| Blake Moore | House | SELL ◆ insider convergence · moderate | Self · Iron Gate GA Brokerage Portfolio > IGGA IRA (BM) | 2024-01-19 | 3 days | — | $1K–$15K 0.1% of NW |
4.9 | ↗ filing |
| Blake Moore | House | SELL ◆ insider convergence · moderate | Self · Iron Gate GA Brokerage Portfolio > IGGA ROTH IRA (BM) | 2024-01-19 | 3 days | — | $1K–$15K 0.1% of NW |
4.9 | ↗ filing |
| Daniel Goldman | House | SELL | Self · Daniel Goldman Grandchildren 1986 Trust > TACS R3K | 2023-04-10 | 23 days | — | $15K–$50K <0.1% of NW |
90.9 | ↗ filing |
| Josh Gottheimer | House | BUY | Joint | 2022-01-10 | 28 days | — | $1K–$15K <0.1% of NW |
10.6 | ↗ filing |
| Josh Gottheimer | House | SELL | Joint | 2021-12-09 | 26 days | — | $1K–$15K <0.1% of NW |
15.7 | ↗ filing |
| Blake Moore | House | BUY | Self | 2021-05-12 | 19 days | — | $1K–$15K 0.1% of NW |
15.7 | ↗ filing |
| Blake Moore | House | BUY | Self | 2021-05-11 | 20 days | — | $1K–$15K 0.1% of NW |
22.3 | ↗ filing |
| Blake Moore | House | BUY | Self | 2021-04-30 | 0 days | — | $1K–$15K 0.1% of NW |
40.4 | ↗ filing |
| Blake Moore | House | BUY | Self | 2021-03-26 | 5 days | — | $1K–$15K 0.1% of NW |
75.9 | ↗ filing |
| Gilbert Cisneros | House | BUY | Self | 2020-07-17 | 33 days | — | $1K–$15K 0.1% of NW |
31.8 | ↗ filing |
| Josh Gottheimer | House | BUY | Joint | 2020-07-09 | 29 days | — | $1K–$15K <0.1% of NW |
31.8 | ↗ filing |
| Gilbert Cisneros | House | BUY | Self | 2020-04-07 | 31 days | — | $1K–$15K 0.1% of NW |
52.4 | ↗ filing |
| Josh Gottheimer | House | BUY | Joint | 2020-04-03 | 33 days | — | $1K–$15K <0.1% of NW |
52.4 | ↗ filing |
| Gilbert Cisneros | House | BUY | Self | 2020-03-31 | 15 days | — | $1K–$15K 0.1% of NW |
86.8 | ↗ filing |
| Josh Gottheimer | House | BUY | Joint | 2020-03-26 | 12 days | — | $1K–$15K <0.1% of NW |
86.8 | ↗ filing |
Corporate insiders · SEC Form 4 Insider Activity
What the company's own officers and directors did in HQY — open-market purchases and sales from SEC Form 4 filings (option exercises, grants and tax withholding are excluded). This is context for the congressional activity above, never a buy/sell signal, and the two datasets are kept separate on purpose. Does convergence mean anything? →
Of the congressional trades in HQY, 10 coincided with corporate insiders moving the same way within 60 days, and 1 with insiders moving the opposite way. This is co-occurrence only — whether it carries any edge is tested honestly on the convergence page.
| Date | Insider | Role | Type | Size | Source |
|---|---|---|---|---|---|
| 2026-10-15 | Rajasekar Sunil | C-suite | BUY | $10K | ↗ EDGAR |
| 2026-08-25 | DILLON ADRIAN T | Director | SELL 10b5-1 | $658K | ↗ EDGAR |
| 2026-08-25 | DILLON ADRIAN T | Director | SELL 10b5-1 | $140K | ↗ EDGAR |
| 2026-08-24 | Rajasekar Sunil | C-suite | SELL | $11K | ↗ EDGAR |
| 2026-07-10 | Fiore Michael Henry | C-suite | SELL 10b5-1 | $224K | ↗ EDGAR |
| 2026-07-08 | Rajasekar Sunil | C-suite | BUY | $2K | ↗ EDGAR |
| 2026-07-02 | Fiore Michael Henry | C-suite | SELL 10b5-1 | $235K | ↗ EDGAR |
| 2026-05-29 | Fiore Michael Henry | C-suite | SELL 10b5-1 | $298K | ↗ EDGAR |
| 2026-05-28 | Ladd Delano | Other | SELL 10b5-1 | $675K | ↗ EDGAR |
| 2026-05-28 | Wellborn Gayle Furgurson | Director | SELL 10b5-1 | $220K | ↗ EDGAR |
| 2026-04-22 | Rajasekar Sunil | C-suite | SELL | $2K | ↗ EDGAR |
| 2025-12-19 | Ladd Delano | Other | SELL 10b5-1 | $142K | ↗ EDGAR |
| 2025-12-18 | Rosner Elimelech | C-suite | SELL | $1.0M | ↗ EDGAR |
| 2025-12-12 | Wellborn Gayle Furgurson | Director | SELL | $425K | ↗ EDGAR |
| 2025-11-20 | Ladd Delano | Other | SELL 10b5-1 | $157K | ↗ EDGAR |
| 2025-10-20 | Ladd Delano | Other | SELL 10b5-1 | $138K | ↗ EDGAR |
| 2025-10-07 | Fiore Michael Henry | C-suite | SELL 10b5-1 | $157K | ↗ EDGAR |
| 2025-09-19 | Ladd Delano | Other | SELL 10b5-1 | $470K | ↗ EDGAR |
| 2025-09-19 | Ladd Delano | Other | SELL 10b5-1 | $92K | ↗ EDGAR |
| 2025-09-19 | Ladd Delano | Other | SELL 10b5-1 | $3K | ↗ EDGAR |
| 2025-09-05 | Dilsaver Evelyn S | Director | SELL | $323K | ↗ EDGAR |
| 2025-07-07 | Fiore Michael Henry | C-suite | SELL 10b5-1 | $111K | ↗ EDGAR |
| 2025-07-07 | Fiore Michael Henry | C-suite | SELL 10b5-1 | $71K | ↗ EDGAR |
| 2025-06-09 | Rosner Elimelech | C-suite | SELL | $1.4M | ↗ EDGAR |
| 2025-06-06 | Rosner Elimelech | C-suite | SELL | $6.5M | ↗ EDGAR |
Combined timeline — Congress & insiders
Both sets of trades on one timeline, newest first, so you can see when they lined up. Congress vs ◆ insider.
| Date | Who | Type | Size | |
|---|---|---|---|---|
| ◆ insider | 2026-10-15 | Rajasekar Sunil C-suite | BUY | $10K |
| ◆ insider | 2026-08-25 | DILLON ADRIAN T Director 10b5-1 | SELL | $658K |
| ◆ insider | 2026-08-25 | DILLON ADRIAN T Director 10b5-1 | SELL | $140K |
| ◆ insider | 2026-08-24 | Rajasekar Sunil C-suite | SELL | $11K |
| Congress | 2026-07-10 | Gilbert Cisneros | BUY | $1K–$15K |
| ◆ insider | 2026-07-10 | Fiore Michael Henry C-suite 10b5-1 | SELL | $224K |
| ◆ insider | 2026-07-08 | Rajasekar Sunil C-suite | BUY | $2K |
| ◆ insider | 2026-07-02 | Fiore Michael Henry C-suite 10b5-1 | SELL | $235K |
| Congress | 2026-06-30 | Gilbert Cisneros | BUY | $1K–$15K |
| Congress | 2026-05-29 | Gilbert Cisneros | BUY | $1K–$15K |
| ◆ insider | 2026-05-29 | Fiore Michael Henry C-suite 10b5-1 | SELL | $298K |
| ◆ insider | 2026-05-28 | Ladd Delano Other 10b5-1 | SELL | $675K |
| ◆ insider | 2026-05-28 | Wellborn Gayle Furgurson Director 10b5-1 | SELL | $220K |
| ◆ insider | 2026-04-22 | Rajasekar Sunil C-suite | SELL | $2K |
| ◆ insider | 2025-12-19 | Ladd Delano Other 10b5-1 | SELL | $142K |
| ◆ insider | 2025-12-18 | Rosner Elimelech C-suite | SELL | $1.0M |
| ◆ insider | 2025-12-12 | Wellborn Gayle Furgurson Director | SELL | $425K |
| ◆ insider | 2025-11-20 | Ladd Delano Other 10b5-1 | SELL | $157K |
| ◆ insider | 2025-10-20 | Ladd Delano Other 10b5-1 | SELL | $138K |
| ◆ insider | 2025-10-07 | Fiore Michael Henry C-suite 10b5-1 | SELL | $157K |
| ◆ insider | 2025-09-19 | Ladd Delano Other 10b5-1 | SELL | $470K |
| ◆ insider | 2025-09-19 | Ladd Delano Other 10b5-1 | SELL | $92K |
| ◆ insider | 2025-09-19 | Ladd Delano Other 10b5-1 | SELL | $3K |
| ◆ insider | 2025-09-05 | Dilsaver Evelyn S Director | SELL | $323K |
FAQ Common questions
How much has Congress traded HQY?
15 disclosed buys and 9 sells of HQY (Healthequity, Inc.) appear in official congressional financial disclosures.
Is it legal for members of Congress to trade HQY?
Members of Congress may trade stocks but must disclose it under the STOCK Act. QuantCapitol tracks those public disclosures for transparency — nothing here is an accusation of wrongdoing or investment advice.
Where does this data come from?
Official US House Clerk and Senate electronic financial disclosures. Every trade links back to its original filing so you can verify it yourself.